RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nasopharyngeal carcinoma: Keytruda overall efficacy = 22%i re-read your post and the Lung cancer NR of TLT ... WOW what a vote of confidence Dr. Yasufuku is putting on TLD-1433 . All these indications , safety and tolerability seems to be fine ( just like a little extra iron <Fe> in the system temporaly ) . Now efficacy is proven in pre-clinicals and human trials are showing 90 days cancer free , waiting on 180 days . Were is the risk ? Can somebody easily imitate TLT ?
Cheers